Ribosomal resistance of clinical enterococcal to streptomycin isolates

Antimicrob Agents Chemother. 1984 Mar;25(3):398-9. doi: 10.1128/AAC.25.3.398.

Abstract

The mechanism of high-level resistance to streptomycin was studied in 12 clinical isolates of Streptococcus faecalis. Six strains produced streptomycin-modifying enzymes. Each of three enzyme-negative strains tested demonstrated ribosomal resistance to streptomycin. Lack of ribosomal susceptibility is a significant cause of high-level streptomycin resistance among clinical enterococcal isolates.

MeSH terms

  • Drug Resistance, Microbial
  • Enterococcus faecalis / drug effects*
  • Enterococcus faecalis / enzymology
  • Humans
  • Kanamycin / pharmacology
  • Nucleotidyltransferases / metabolism
  • Phenylalanine / metabolism
  • Ribosomes / drug effects*
  • Streptococcal Infections / microbiology
  • Streptomycin / pharmacology*

Substances

  • Phenylalanine
  • Kanamycin
  • Nucleotidyltransferases
  • streptomycin 3''-adenylyltransferase
  • Streptomycin